SHARE-BASED COMPENSATION (Tables)

9 Months Ended

Jul. 28, 2024

The table below presents information on our share-based compensation expenses for the three and nine-month periods ended July 28, 2024 and July 30, 2023.

	Three Months Ended				Nine Months Ended
	July 28, 2024		July 30, 2023		July 28, 2024		July 30, 2023
Expense reported in:
Cost of goods sold	$	683	$	322	$	1,946	$	892
Selling, general, and administrative		2,388		1,499		7,126		4,407
Research and development		271		222		769		575
Total expense incurred	$	3,342	$	2,043	$	9,841	$	5,874

Expense by award type:
Restricted stock awards	$	3,342	$	2,043	$	9,841	$	5,782
Stock options		-		-		-		1
Employee stock purchase plan		-		-		-		91
Total expense incurred	$	3,342	$	2,043	$	9,841	$	5,874

Income tax benefits of share-based compensation	$	323	$	152	$	745	$	513

Restricted Stock Awards Activity

The table below presents information on our restricted stock awards for the three and nine-month periods ended July 28, 2024 and July 30, 2023.

	Three Months Ended				Nine Months Ended
	July 28, 2024		July 30, 2023		July 28, 2024		July 30, 2023
Number of shares granted in period		-		-		825,050		786,500
Weighted-average grant-date fair value of awards (in dollars per share)	$	-	$	-	$	29.77	$	16.77
Compensation cost not yet recognized	$	25,750	$	14,511	$	25,750	$	14,511
Weighted-average amortization period for cost not yet recognized (in years)		2.9		2.9		2.9		2.9
Shares outstanding at balance sheet date		1,513,827		1,267,247		1,513,827		1,267,247

Stock Options Activity

The table below presents information on our stock options for three and nine-month periods ended July 28, 2024 and July 30, 2023.

	Three Months Ended				Nine Months Ended
	July 28, 2024		July 30, 2023		July 28, 2024		July 30, 2023
Number of options granted in period		-		-		-		-
Cash received from option exercised	$	20	$	512	$	1,074	$	1,094
Compensation cost not yet recognized	$	-	$	-	$	-	$	-
Weighted-average amortization period for cost not yet recognized (in years)		-		-		-		-

Outstanding and Exercisable Option

Information respecting outstanding and exercisable option awards as of July 28, 2024, is presented below.

Options		Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life (in years)				Aggregate Intrinsic Value
Outstanding and exercisable at July 28, 2024			358,125			$	10.33				2.08			$	5,476